glp-1 drugs competitive intelligence 2025 2025’s Breakthrough Obesity Treatments: Top Companies & Innovations GLP-1 Market Size, Share |

For most GLP-1 weight management medications, Anthem requires a BMI of 30 or greater (clinical obesity) or a BMI of 27 or greater with at least one weight-related comorbidity

But then in 2025, something changed

Six studies assessed all three eligible tirzepatide maintenance doses (5, 10 and 15 mg once-weekly), while one study included two arms with a maintenance dose of 15 mg but with two different dose-escalation regimens [18]

Alcohol can also lead to disinhibited eating and dehydration, further complicating your nutrition and hydration goals

Natural GLP-1 Support Comparison Are Natural Alternatives as Effective as GLP-1 Drugs

17 July 2026